Clinical Trials Logo

Clinical Trial Summary

Our study utilizes a 3-arm placebo-controlled RCT to study the effectiveness of ketamine in reducing chronic post-mastectomy pain. Participants randomized to the first arm will receive a 0.35 mg/kg dose after induction, followed by a 0.3 mg/kg/hr infusion throughout surgery and continued for 2 hours postoperatively. Participants in the second arm will receive a single dose of 0.6 mg/kg of ketamine in the post-anesthesia care unit, and the final group will serve as the control group and receive saline (no ketamine).

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05037123
Study type Interventional
Source NYU Langone Health
Contact Jing Wang, MD, PhD
Phone 212-263-5072
Email [email protected]
Status Not yet recruiting
Phase Phase 3
Start date October 1, 2021
Completion date October 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04924010 - Effect of Perioperative CBT on Chronic Persistent Postsurgical Pain Among Breast Cancer Patients N/A
Not yet recruiting NCT04866147 - Prediction of Chronic Postsurgical Pain in Adults
Completed NCT01537731 - Vaginal or Laparoscopic Hysterectomy, Persistent Postsurgical Pain N/A
Recruiting NCT03847363 - The Influence of Different Anesthesia on Acute and Chronic Postsurgical Pain After Thoracic Surgery